Company / SG&A per Share
CHAMPIONS ONCOLOGY, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.81
FY2025
5-year range
$0.49 / $0.81
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has increased for 3 consecutive years, from $0.49 in FY2022 to $0.81 in FY2025.
Based on SEC 10-K filings.
0.81 in FY2025 with a 5-year CAGR of +7.8%.
Increased from $0.67 to $0.81 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- CHAMPIONS ONCOLOGY, INC.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 18.1% year-over-year.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.81 | +18.1% |
| FY2024 | $0.69 | +2.3% |
| FY2023 | $0.67 | +38.9% |
| FY2022 | $0.49 | -6.6% |
| FY2021 | $0.52 | -7.3% |
| FY2020 | $0.56 | -6.8% |
| FY2019 | $0.60 | +33.0% |
| FY2018 | $0.45 | -24.0% |
| FY2017 | $0.59 | -3.3% |
| FY2016 | $0.61 | +570.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026